Suano, Mcknzy .

HRN: 22-59-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2023
CEFUROXIME 750MG (VIAL)
02/19/2023
02/26/2023
IV
750 Mg
Q8
Age With Mod; T/C Amoebiasis, URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaIntra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: